SU539538A3 - Способ получени метаболита "а 27 106 - Google Patents

Способ получени метаболита "а 27 106

Info

Publication number
SU539538A3
SU539538A3 SU2002131A SU2002131A SU539538A3 SU 539538 A3 SU539538 A3 SU 539538A3 SU 2002131 A SU2002131 A SU 2002131A SU 2002131 A SU2002131 A SU 2002131A SU 539538 A3 SU539538 A3 SU 539538A3
Authority
SU
USSR - Soviet Union
Prior art keywords
medium
streptomyces
substance
monensin
nrrl
Prior art date
Application number
SU2002131A
Other languages
English (en)
Russian (ru)
Inventor
Рэй Браннон Дональд
Рой Хортон Дональд
Original Assignee
Эли Лилли Энд Компани (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани (Фирма) filed Critical Эли Лилли Энд Компани (Фирма)
Application granted granted Critical
Publication of SU539538A3 publication Critical patent/SU539538A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SU2002131A 1973-02-01 1974-02-01 Способ получени метаболита "а 27 106 SU539538A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32858673A 1973-02-01 1973-02-01

Publications (1)

Publication Number Publication Date
SU539538A3 true SU539538A3 (ru) 1976-12-15

Family

ID=23281582

Family Applications (1)

Application Number Title Priority Date Filing Date
SU2002131A SU539538A3 (ru) 1973-02-01 1974-02-01 Способ получени метаболита "а 27 106

Country Status (27)

Country Link
JP (2) JPS5730477B2 (US06252093-20010626-C00008.png)
AR (1) AR206509A1 (US06252093-20010626-C00008.png)
AT (1) AT328083B (US06252093-20010626-C00008.png)
BE (1) BE810416A (US06252093-20010626-C00008.png)
BG (1) BG26953A3 (US06252093-20010626-C00008.png)
CA (1) CA1016483A (US06252093-20010626-C00008.png)
CH (1) CH589140A5 (US06252093-20010626-C00008.png)
CS (1) CS193481B2 (US06252093-20010626-C00008.png)
DD (1) DD112441A5 (US06252093-20010626-C00008.png)
DE (1) DE2404958C2 (US06252093-20010626-C00008.png)
DK (1) DK143036C (US06252093-20010626-C00008.png)
EG (1) EG11287A (US06252093-20010626-C00008.png)
ES (1) ES422834A1 (US06252093-20010626-C00008.png)
FI (1) FI52993C (US06252093-20010626-C00008.png)
FR (1) FR2215943B1 (US06252093-20010626-C00008.png)
GB (1) GB1457796A (US06252093-20010626-C00008.png)
HU (1) HU167276B (US06252093-20010626-C00008.png)
IE (1) IE38780B1 (US06252093-20010626-C00008.png)
IL (1) IL44065A (US06252093-20010626-C00008.png)
IN (1) IN139462B (US06252093-20010626-C00008.png)
NL (1) NL181367C (US06252093-20010626-C00008.png)
NO (1) NO139788C (US06252093-20010626-C00008.png)
PH (1) PH12449A (US06252093-20010626-C00008.png)
SE (1) SE401930B (US06252093-20010626-C00008.png)
SU (1) SU539538A3 (US06252093-20010626-C00008.png)
YU (1) YU36990B (US06252093-20010626-C00008.png)
ZA (1) ZA74464B (US06252093-20010626-C00008.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6384471U (US06252093-20010626-C00008.png) * 1986-11-21 1988-06-02
JPH0532866Y2 (US06252093-20010626-C00008.png) * 1987-10-27 1993-08-23
JPH0483920U (US06252093-20010626-C00008.png) * 1990-11-30 1992-07-21
JPH0512236U (ja) * 1991-07-26 1993-02-19 東京ラヂエーター製造株式会社 燃料タンクの燃料吹き返し防止構造

Also Published As

Publication number Publication date
ATA76874A (de) 1975-05-15
YU19074A (en) 1982-02-25
JPS5798211A (en) 1982-06-18
JPS5730477B2 (US06252093-20010626-C00008.png) 1982-06-29
IE38780L (en) 1974-08-01
DE2404958C2 (de) 1985-04-18
DK143036B (da) 1981-03-16
FI52993B (US06252093-20010626-C00008.png) 1977-09-30
IL44065A (en) 1977-03-31
DE2404958A1 (de) 1974-08-22
CH589140A5 (US06252093-20010626-C00008.png) 1977-06-30
NO139788C (no) 1979-05-09
IE38780B1 (en) 1978-05-24
ZA74464B (en) 1975-08-27
ES422834A1 (es) 1976-09-16
YU36990B (en) 1984-08-31
NO139788B (no) 1979-01-29
IN139462B (US06252093-20010626-C00008.png) 1976-06-19
HU167276B (US06252093-20010626-C00008.png) 1975-09-27
FI52993C (US06252093-20010626-C00008.png) 1978-01-10
JPS49102888A (US06252093-20010626-C00008.png) 1974-09-28
CA1016483A (en) 1977-08-30
FR2215943A1 (US06252093-20010626-C00008.png) 1974-08-30
GB1457796A (en) 1976-12-08
JPS6026374B2 (ja) 1985-06-24
IL44065A0 (en) 1974-05-16
PH12449A (en) 1979-03-08
FR2215943B1 (US06252093-20010626-C00008.png) 1978-07-28
NL181367B (nl) 1987-03-02
AT328083B (de) 1976-03-10
EG11287A (en) 1977-01-31
NO740292L (no) 1974-08-02
DK143036C (da) 1981-10-26
BE810416A (fr) 1974-07-31
AU6473774A (en) 1975-07-24
DD112441A5 (US06252093-20010626-C00008.png) 1975-04-12
BG26953A3 (US06252093-20010626-C00008.png) 1979-07-12
AR206509A1 (es) 1976-07-30
NL181367C (nl) 1987-08-03
NL7401311A (US06252093-20010626-C00008.png) 1974-08-05
SE401930B (sv) 1978-06-05
CS193481B2 (en) 1979-10-31

Similar Documents

Publication Publication Date Title
CA1338185C (en) Glycosidase inhibitor salbostatin, process for its preparation, and its use
US5294546A (en) Method for production of a growth factor for Bifidobacterium sp.
SU695565A3 (ru) Способ получени клавулановой кислоты и ее солей
US2483892A (en) Process for the manufacture of chloramphenicol
US3085049A (en) Process for producing vitamin b12 and antibiotics
US5902579A (en) Natamycin-containing streptomyces biomass and its use in animal feed
SU539538A3 (ru) Способ получени метаболита "а 27 106
Kim et al. STUDIES ON MIKAMYCIN B LACTONASE I. DEGRADATION OF MIKAMYCIN B BY STREPTOMYCES MITAKAENSIS
US4229539A (en) β-Galactosidase and production thereof
CA1302927C (en) Efomycin g, its preparation and its use as a yield promoter in animals
US4770876A (en) Microbiological production of livestock growth-promoting agent
JPH066061B2 (ja) ε−ポリリシンの製造方法およびε−ポリリシン生産菌
US3932619A (en) Metabolite A-27106 and processes for its preparation and use
US3898133A (en) Process of preparing an enzyme with lipolytic activity
US2996435A (en) Process for producing azaserine
US4262002A (en) Discovery of A73A, a new efrotomycin-like antibiotic in fermentation broth
US3230153A (en) Process for the production of regulin by aspergillus restrictus and resulting product
CA1334741C (en) Method for production of a growth factor for bifidobacterium sp
US2596969A (en) Fermentation process for producing grisein
US4197292A (en) Novel amylase inhibitors
US4132779A (en) Antibiotic BL580 Zeta and use thereof as anticoccidial agent
JPS6391076A (ja) 3種菌の培養法
US3849552A (en) Protease inhibitors and method for preparation
SU618053A3 (ru) Способ получени антибактериального вещества
US2647074A (en) Production of riboflavin by microbiological fermentation